AGIOS PHARMACEUTICALS, INC. Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 36,152 | 0 | 109,230 | 73.1 K to 109.2 K (+49.47 %) |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 25,412 | 0 | 73,078 | 47.7 K to 73.1 K (+53.31 %) |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 48.75 | 8,400 | 409,482 | 283,681 | 292.1 K to 283.7 K (-2.88 %) |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 47.73 | 42,596 | 2,032,979 | 292,081 | 334.7 K to 292.1 K (-12.73 %) |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.35 | 1,000 | 50,346 | 334,677 | 335.7 K to 334.7 K (-0.30 %) |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 49.90 | 46,938 | 2,342,408 | 335,677 | 382.6 K to 335.7 K (-12.27 %) |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.56 | 34,650 | 1,751,821 | 382,615 | 417.3 K to 382.6 K (-8.30 %) |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 54.17 | 1,780 | 96,428 | 417,265 | 419 K to 417.3 K (-0.42 %) |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 50.40 | 142,900 | 7,202,160 | 142,900 | |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
| Feb 17 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 201,656 | |
| Feb 17 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 50.01 | 6,000 | 300,060 | 0 | 6 K to 0 (-100.00 %) |
| Feb 17 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |